Home » Topics » Conferences

Conferences
RSS

New antidiabetic agent presented by Bayer scientists this week in San Diego

June 21, 1999

Antifilarial efficacy of PF-1022A demonstrated in gerbil model

June 21, 1999

Japanese investigators explore natural sources for novel antimalarial agents

June 21, 1999

Trimegestone is potentially superior to MPA for HRT

June 21, 1999

Dutasteride suppresses DHT levels more effectively, consistently than finasteride

June 21, 1999

Parathyroid hormone plus estrogen restores bone density to normal levels in osteoporotic women

June 21, 1999

Role of imidazoline receptors in hypertension

June 21, 1999

FPTO, a novel cardiovascular agent acting via NO pathways

June 21, 1999

Orally active GnRH antagonist evaluated in preclinical models by Abbott investigators

June 18, 1999

A-198401: another compound emerges from Abbott's focus on nonpeptide GnRH antagonists

June 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.